DEZLUMIA Trademark

Trademark Overview

On Monday, August 30, 2021, a trademark application was filed for DEZLUMIA with the United States Patent and Trademark Office. The USPTO has given the DEZLUMIA trademark a serial number of 97002052. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, July 23, 2024. This trademark is owned by Biohaven Therapeutics Ltd.. The DEZLUMIA trademark is filed in the Pharmaceutical Products category with the following description:

Medicated and pharmaceutical preparations, both prescription and over-the-counter, for use in connection with humans, namely, for the treatment of neuroinflammatory and neurodegenerative diseases and disorders, and for neuroprotection
dezlumia

General Information

Serial Number97002052
Word MarkDEZLUMIA
Filing DateMonday, August 30, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, July 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 11, 2022

Trademark Statements

Goods and ServicesMedicated and pharmaceutical preparations, both prescription and over-the-counter, for use in connection with humans, namely, for the treatment of neuroinflammatory and neurodegenerative diseases and disorders, and for neuroprotection

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 13, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBiohaven Therapeutics Ltd.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressRoad Town, Tortola VG1110
VG
Party NameBiohaven Therapeutics Ltd.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressNew Haven, CT 06510

Trademark Events

Event DateEvent Description
Monday, December 6, 2021ASSIGNED TO EXAMINER
Thursday, September 2, 2021NEW APPLICATION ENTERED
Wednesday, October 13, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, December 7, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 22, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 11, 2022PUBLISHED FOR OPPOSITION
Tuesday, January 11, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 8, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, September 8, 2022SOU TEAS EXTENSION RECEIVED
Thursday, September 8, 2022SOU EXTENSION 1 FILED
Thursday, September 8, 2022SOU EXTENSION 1 GRANTED
Saturday, September 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 23, 2023SOU TEAS EXTENSION RECEIVED
Thursday, February 23, 2023SOU EXTENSION 2 FILED
Thursday, February 23, 2023SOU EXTENSION 2 GRANTED
Saturday, February 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 17, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, April 17, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, April 17, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, June 26, 2023SOU TEAS EXTENSION RECEIVED
Monday, June 26, 2023SOU EXTENSION 3 FILED
Monday, June 26, 2023SOU EXTENSION 3 GRANTED
Wednesday, June 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 25, 2024SOU TEAS EXTENSION RECEIVED
Thursday, January 25, 2024SOU EXTENSION 4 FILED
Thursday, January 25, 2024SOU EXTENSION 4 GRANTED
Tuesday, July 23, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, July 23, 2024SOU EXTENSION 5 GRANTED
Tuesday, July 23, 2024SOU EXTENSION 5 FILED
Wednesday, July 24, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, January 27, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

dezlumia neuroinflammatory treatment namely neurodegenerative diseases neuroprotection disorders humans connection preparations